Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Spiller

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Trials|August 21, 2019
Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trialDavid Gunn, Ron Fried, Rabia Lalani, et al.
Nature Genetics|November 6, 2021
Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disordersChris Eijsbouts, Tenghao Zheng, Nicholas A Kennedy, et al.
World Journal of Gastroenterology|July 8, 2022
Serotonin type 3 receptor subunit gene polymorphisms associated with psychosomatic symptoms in irritable bowel syndrome: A multicenter retrospective studySabrina Berens, Yuanjun Dong, Nikola Fritz, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 19, 2022
The serotonin receptor 3E variant is a risk factor for female IBS-DNikola Fritz, Sabrina Berens, Yuanjun Dong, et al.
Journal of Cellular and Molecular Medicine|June 24, 2021
The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndromeSandra Mohr, Nikola Fritz, Christian Hammer, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Trials|August 21, 2019
Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trialDavid Gunn, Ron Fried, Rabia Lalani, et al.
Nature Genetics|November 6, 2021
Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disordersChris Eijsbouts, Tenghao Zheng, Nicholas A Kennedy, et al.
World Journal of Gastroenterology|July 8, 2022
Serotonin type 3 receptor subunit gene polymorphisms associated with psychosomatic symptoms in irritable bowel syndrome: A multicenter retrospective studySabrina Berens, Yuanjun Dong, Nikola Fritz, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 19, 2022
The serotonin receptor 3E variant is a risk factor for female IBS-DNikola Fritz, Sabrina Berens, Yuanjun Dong, et al.
Journal of Cellular and Molecular Medicine|June 24, 2021
The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndromeSandra Mohr, Nikola Fritz, Christian Hammer, et al.
Pageof 9